The Motley Fool

Why these 4 ASX shares surged higher today

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) hasn’t been able to follow up on yesterday’s gains and afternoon trade has fallen 0.3% to 5,742 points. Today’s decline is largely down to steep declines in the utilities and materials sectors.

Four shares which have gone against the grain today and jumped higher are listed below. Here’s why they’ve surged higher:

The Bubs Australia Ltd (ASX: BUB) share price is up almost 11% to 10.5 cents after the infant formula and baby food company announced a supply agreement with retail giant Costco. The deal will see Costco offer Bubs infant formula products in its wholesale catalogue nationally and at one of its warehouses in Sydney.

The Capitol Health Ltd (ASX: CAJ) share price has jumped almost 7% to 16 cents despite there being no news out of the diagnostic imaging company. Capitol Health recently raised $38.5 million in order to reduce its debt levels. Management believes the improved balance sheet now provides it with a platform for growth.

The Impedimed Limited (ASX: IPD) share price has followed up on yesterday’s rise with a 3.5% gain to 72.5 cents. Investors have been snapping up the medical device company’s shares after it announced that its first SOZO device had been placed with Scripps Health in the United States. Management is targeting the chronic heart failure market which impacts an estimated 5.7 million people in the country.

The Mesoblast limited (ASX: MSB) share price has also climbed for a second day in a row, this time by 3.5% to $2.01. Yesterday the U.S. Food and Drug Administration granted its MSC-100-IV cell therapy fast-track status. This has the potential to shorten the time to FDA approval. So much so management appears confident that a single successful open-label Phase 3 trial will be sufficient for conditional FDA approval. Whilst this is promising news, I feel it is a little early for an investment.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

*Returns as of June 30th

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Related Articles...